December 1, 2013- National Coverage Decisions (NCDs) are used by CMS to set guidelines as to when certain therapies will be covered and reimbursed based on the best scientific clinical data. NCD’s tend to result in restricted usage of a formerly overused and costly therapy. Recently, two controversial therapies, Provenge for prostate cancer and the Edwards Lifesciences’ Sapien percutaneous aortic valve, have been restricted by NCD’s. We asked former Director of CMS, Dr. Don Berwick, whether this will be an increasingly used tool by Medicare to cut costs.
Recent Comments
- E L on Exclusive: The gender reassignment butchers have taken over my NYU surgery
- LoveKatz67 on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
- Truth Clearware on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
- EricUniqueUsername on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
- ThunderbirdRocket on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
Most Viewed Posts
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (14,194)
- New treatment paradigm for C. Diff colitis (14,092)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (13,610)
- How the FDA regulates compounding pharmacies (13,257)
- The Healthcare Channel hits 10 (12,212)
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (11,256)
- The new CDC guidelines for prescribing opioid pain pills (8,036)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (7,185)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (7,031)
- The MusiCorps benefit concert 2015 (6,081)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale